Doctors have a new blood test available to help investigate possible Alzheimer’s disease in people who are already showing ...

It is the first test the FDA has cleared for use in symptomatic adults aged 40 and over, according to C2N Diagnostics.

Suffescom Solutions Inc. CEO Gurpreet Singh Walia explains how validation, governance, and human oversight prepare diagnostic ...

The US Food and Drug Administration has given the go-ahead for a new test to confirm or rule out the presence of amyloidosis ...

Blood-based test identifies presence of amyloid plaques in symptomatic adults and is intended to be used in conjunction with a clinical assessment ...

Elecsys pTau217 is a blood test from Roche that can be used to rule in or rule out the presence of amyloid plaques, which are ...

Will getting a blood test for amyloid levels eventually form part of routine primary care health checks, or are we putting ...

The US Food & Drug Administration (FDA) has cleared the use of a new single-biomarker blood test to help doctors look for signs of Alzheimer’s disease in people 55 and older with signs or symptoms ...

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced the publication of new ...

Regular prostate cancer screening is not recommended for all men. Here’s why. Why doesn’t my doctor automatically order a PSA ...

Not all breast cancers are the same, and healthcare professionals classify the type to determine treatment options.